Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trialLars Wallentin, Stuart J. Connolly, Marcus Flather et al.|The Lancet|2010Cited by 1k
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysisPhilip Joseph, Salim Yusuf, Gholamreza Roshandel et al.|The Lancet|2021Cited by 148